TELA Bio outlines $76M-$78M 2027 expense range following $17M cost reduction plan
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
CD&R’s Cornerstone to Go Ahead With Monarch Deal to Raise Money
Cornerstone Building Brands Inc. is set to move forward on a deal it reached with Monarch Alternative Capital to raise additional liquidity after months of negotiations with existing lenders…
